Clinical Trial Update: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [NA]

View source ↗

Summary

A clinical trial compares purified CD34+ cell therapy to peripheral blood mononuclear cells for treating critical limb ischemia, sponsored by Shanghai Zhongshan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteritis
• Critical Limb Ischemia
• Peripheral Arterial Disease
• Thromboangiitis Obliterans

Drugs mentioned

• Peripheral blood mononuclear cells (PBMCs)
• Purified CD34+ cells (CD34+ cell therapy)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Thromboangiitis Obliterans, Arteritis | NA | Status: UNKNOWN